KAWAKAMI MARK (Chief Financial Officer) purchased 35.3% of their position (700.00 shares) of ARCADIA BIOSCIENCES, INC. on the open market
Open‑market purchase worth $1.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/5/2025ACC: 0000950170-25-014814
Officer· Chief Financial Officer
Since Jul 2024
+700.00
Net shares
Net buyer
$1.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
700.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+700.00
Price / share
$2.49
Trade value
$1.74K
% of position
35.3%
2/3/2025
1.98K→2.68K
Total
Net shares
+700.00
Net value
$1.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | P · Purchase | +700.00 | $2.49 | $1.74K | 35.3% | 1.98K | 2.68K |
| Total | +700.00 | $1.74K | ||||||
Derivative Transactions0
No derivative transactions reported